SAN-LINA-M
Description_Effects
SAN-LINA-M is a prescription medication used in the management of type 2 diabetes mellitus. It is a combination of Linagliptin 5 mg and Metformin 500 mg (extended-release), two antidiabetic agents that work synergistically to lower blood glucose levels effectively and safely. Metformin, a biguanide, primarily works by reducing the amount of glucose produced by the liver and improving the body's response to insulin. It also decreases the absorption of glucose from the intestines, leading to better glycemic control. Linagliptin, a DPP-4 inhibitor, enhances the activity of incretin hormones, which increase insulin secretion in response to meals and reduce glucagon release, thereby lowering blood sugar levels. Together, these two agents help control both fasting and post-meal blood glucose levels, making SAN-LINA-M a powerful option for people struggling to manage their diabetes through lifestyle changes and single-drug therapy alone. Effective blood sugar management is crucial in preventing long-term complications such as kidney damage, nerve issues, vision problems, and even cardiovascular events like heart attacks and strokes. When used consistently along with a healthy diet, regular exercise, and monitoring, SAN-LINA-M can support long-term well-being and improve quality of life. It is important to continue taking this medication exactly as prescribed and attend regular follow-ups with your doctor to monitor blood sugar levels and overall health.
